dimyristoylphosphatidylcholine has been researched along with Osteosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, K; Ichihara, H; Kitajima, H; Komizu, Y; Ueoka, R | 1 |
| Kitajima, H; Komizu, Y; Ueoka, R | 1 |
2 other study(ies) available for dimyristoylphosphatidylcholine and Osteosarcoma
| Article | Year |
|---|---|
Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Dimyristoylphosphatidylcholine; Liposomes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Osteosarcoma; Polidocanol; Polyethylene Glycols; Random Allocation | 2013 |
Hybrid liposomes inhibit growth and invasion of human osteosarcoma cells leading to apoptosis.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Dimyristoylphosphatidylcholine; Flow Cytometry; Humans; Inhibitory Concentration 50; Liposomes; Molecular Structure; Neoplasm Invasiveness; Osteosarcoma; Polyethylene Glycols | 2012 |